Search
for
Sort by
Research 31–60 of 230
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Ritlecitinib: First Approval
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- A novel therapeutic paradigm for patients with extensive alopecia areata
- New drugs under investigation for the treatment of alopecias
- Genome-wide association study of skin complex diseases
- The Genetics of Human Skin Disease
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- The Genetics of Seborrheic Dermatitis: A Candidate Gene Approach and Pilot Genome-Wide Association Study
- Dengue Virus Infects Primary Human Hair Follicle Dermal Papilla Cells
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Transcriptional Profiling in Rat Hair Follicles following Simulated Blast Insult: A New Diagnostic Tool for Traumatic Brain Injury
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Current and future pharmacotherapy for alopecia areata
- ROS-scavenging microneedles loaded with <i>Portulaca oleracea</i> L.-derived exosomes for atopic dermatitis therapy
- New therapies for alopecia areata
- The role of janus kinases in the treatment of autoimmune skin diseases
- Androgenic Alopecia: Cross-Talk Between Cell Signal Transduction Pathways
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications